Evidence map›Paper›PMID 29240829›Full record

ArticlePloS one2017

CELSR2 is a candidate susceptibility gene in idiopathic scoliosis.

Elisabet Einarsdottir, Anna Grauers, Jingwen Wang, Hong Jiao, Stefan A Escher, Aina Danielsson, Ane Simony, Mikkel Andersen, Steen Bach Christensen, Kristina Åkesson and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 6 countries.

Elisabet EinarsdottirFolkhälsan Institute of Genetics, and Molecular Neurology Research Program, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-3101-2285
Anna GrauersDepartment of Orthopaedics, Sundsvall and Härnösand County Hospital, Sundsvall, Sweden.
Jingwen WangDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Hong JiaoDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Stefan A EscherGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Aina DanielssonDepartment of Orthopaedics, Institute of Clinical Sciences, Sahlgren Academy at Gothenburg University, Göteborg, Sweden.
Ane SimonySector for Spine Surgery & Research, Middelfart Hospital, Middelfart, Denmark.
Mikkel AndersenSector for Spine Surgery & Research, Middelfart Hospital, Middelfart, Denmark.
Steen Bach ChristensenSector for Spine Surgery & Research, Middelfart Hospital, Middelfart, Denmark.
Kristina ÅkessonLund University, Department of Clinical Sciences Malmö, Clinical and Molecular Osteoporosis Research Unit, Malmö, Sweden.
Ikuyo KouLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan.
Anas M KhanshourSarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas, United States of America.
Acke OhlinDepartment of Orthopaedics, Skåne University Hospital, Malmö, Sweden.
Carol WiseSarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas, United States of America.
Shiro IkegawaLaboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan.
Juha KereFolkhälsan Institute of Genetics, and Molecular Neurology Research Program, University of Helsinki, Helsinki, Finland.
Paul GerdhemDepartment of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SERegional Hospital Central Jutland · DKLund University · SERIKEN Center for Integrative Medical Sciences · JPTexas Scottish Rite Hospital for Children · USGuy's Hospital · GBKarolinska University Hospital · SESahlgrenska University Hospital · SESkåne University Hospital · SEUniversity of Helsinki · FI

Funding

Non-coding/epigenetic regulationP01HD084387 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI Nadav Ahituv, LILIANNA SOLNICAKREZEL · 2016 to 2026
$14.2M
NICHD NIH HHS P01 HD084387
6 · The paper itself

Abstract

A Swedish pedigree with an autosomal dominant inheritance of idiopathic scoliosis was initially studied by genetic linkage analysis, prioritising genomic regions for further analysis. This revealed a locus on chromosome 1 with a putative risk haplotype shared by all affected individuals. Two affected individuals were subsequently exome-sequenced, identifying a rare, non-synonymous variant in the CELSR2 gene. This variant is rs141489111, a c.G6859A change in exon 21 (NM_001408), leading to a predicted p.V2287I (NP_001399.1) change. This variant was found in all affected members of the pedigree, but showed reduced penetrance. Analysis of tagging variants in CELSR1-3 in a set of 1739 Swedish-Danish scoliosis cases and 1812 controls revealed significant association (p = 0.0001) to rs2281894, a common synonymous variant in CELSR2. This association was not replicated in case-control cohorts from Japan and the US. No association was found to variants in CELSR1 or CELSR3. Our findings suggest a rare variant in CELSR2 as causative for idiopathic scoliosis in a family with dominant segregation and further highlight common variation in CELSR2 in general susceptibility to idiopathic scoliosis in the Swedish-Danish population. Both variants are located in the highly conserved GAIN protein domain, which is necessary for the auto-proteolysis of CELSR2, suggesting its functional importance.

Indexed as

Genetic Predisposition to DiseaseCadherinsCase-Control StudiesCohort StudiesDenmarkExome SequencingFemaleGenes, DominantGenetic LinkageGenotypeHumansMalePedigreeScoliosisSwedenUnited StatesCadherinsCELSR2 protein, human

Identifiers

PMID29240829
PMCPMC5730153
OpenAlexW2771363460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.